These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10434283)

  • 1. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products.
    Shah VP; Elkins JS; Williams RL
    Pharm Dev Technol; 1999 Aug; 4(3):377-85. PubMed ID: 10434283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro release of betamethasone dipropionate from petrolatum-based ointments.
    Zatz JL; Varsano J; Shah VP
    Pharm Dev Technol; 1996 Oct; 1(3):293-8. PubMed ID: 9552312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release of hydrocortisone from topical preparations and automated procedure.
    Shah VP; Elkins J; Hanus J; Noorizadeh C; Skelly JP
    Pharm Res; 1991 Jan; 8(1):55-9. PubMed ID: 2014209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro release from corticosteroid ointments.
    Shah VP; Elkins JS
    J Pharm Sci; 1995 Sep; 84(9):1139-40. PubMed ID: 8537896
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of betamethasone dipropionate and salicylic acid in pharmaceutical preparations by high-performance liquid chromatography.
    Kedor-Hackmann ER; Gianotto EA; Santoro MI
    Drug Dev Ind Pharm; 1998 Jun; 24(6):553-5. PubMed ID: 9876622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of different test parameters on in vitro drug release from topical diclofenac formulations in a vertical diffusion cell setup.
    Klein S
    Pharmazie; 2013 Jul; 68(7):565-71. PubMed ID: 23923638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of topical gels with betamethasone dipropionate: selection of gel forming and optimal cosolvent system.
    Băiţan M; Lionte M; Moisuc L; Gafiţanu E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):601-5. PubMed ID: 21870764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical corticosteroids: quality control considerations.
    Shah VP
    Int J Dermatol; 1992 Oct; 31 Suppl 1():34-7. PubMed ID: 1428466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams.
    Shah VP; Elkins J; Skelly JP
    J Pharm Sci; 1992 Jan; 81(1):104-6. PubMed ID: 1619561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of creams with betamethasone dipropionate: evaluation of chemical stability.
    Băiţan M; Gafiţanu E; Lionte M; Moisuc L
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):600-4. PubMed ID: 20701012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equipment and method for in vitro release measurements on topical dosage forms.
    Sesto Cabral ME; Ramos AN; Cabrera CA; Valdez JC; González SN
    Pharm Dev Technol; 2015; 20(5):619-25. PubMed ID: 25318476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment.
    Sequira J; Berardi M; Chan TM; Letarte J; Malchow R; Pramanick B; Wolkoff HN
    Clin Ther; 1991; 13(6):687-94. PubMed ID: 1790543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis.
    Queille-Roussel C; Hoffmann V; Enevold A; Ganslandt C
    J Dermatolog Treat; 2013 Aug; 24(4):250-4. PubMed ID: 22103604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development in release testing of topical dosage forms: use of the Enhancer Cell with automated sampling.
    Rege PR; Vilivalam VD; Collins CC
    J Pharm Biomed Anal; 1998 Sep; 17(8):1226-33. PubMed ID: 9800641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in first-line topical therapies: the role of a 2-compound ointment for psoriasis vulgaris.
    Lebwohl MG
    Cutis; 2007 Jan; 79(1 Suppl 2):3-4. PubMed ID: 17367039
    [No Abstract]   [Full Text] [Related]  

  • 16. RP-HPLC method for simultaneous determination of butenafine hydrochloride and betamethasone dipropionate in a cream formulation.
    Bhosale SD; Rajput SJ
    J AOAC Int; 2011; 94(1):106-9. PubMed ID: 21391486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on the therapeutic activity of a betamethasone dipropionate - iodochloroxyquinoline combination for topical use].
    Sartoris S; Paggio A; De Santolo GP
    G Ital Dermatol Venereol; 1983; 118(6):LI-LIV. PubMed ID: 6232210
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability of topical steroids.
    Barry BW
    Dermatologica; 1976; 152 Suppl 1():47-65. PubMed ID: 955238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
    Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
    Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatologic investigation of betamethasone 17,21-dipropionate ointment with chinoform.
    Tollofsrud A
    J Int Med Res; 1977; 5(2):132-5. PubMed ID: 141383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.